Back to mobile site

AngioDynamics (ANGO) Tops Q1 EPS by 5c ; Offers Guidance

October 3, 2024 6:32 AM EDT

AngioDynamics (NASDAQ: ANGO) reported Q1 EPS of ($0.11), $0.05 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $67.5 million versus the consensus estimate of $69 million.

GUIDANCE:

AngioDynamics sees FY2025 EPS of ($0.38)-($0.42), versus the consensus of ($0.41). AngioDynamics sees FY2025 revenue of $282-288 million, versus the consensus of $284.4 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK